Simultaneous population pharmacokinetic modelling of darunavir and ritonavir Once daily in HIV-infected patients: evaluation of lower ritonavir dose

被引：0
|
作者：
Dickinson, L. [1 ]
Jackson, A. [2 ]
Garvey, L. [3 ]
Watson, V [1 ]
Khoo, S. [1 ]
Winston, A. [3 ]
Boffito, M. [2 ]
Davies, G. [1 ]
Back, D. [1 ]
机构：
[1] Univ Liverpool, Dept Mol & Clin Pharmacol, Pharmacol Res Labs, Liverpool L69 3BX, Merseyside, England
[2] Chelsea & Westminster Fdn Trust, St Stephens Ctr, London, England
[3] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Dept HIV & GU Med, London, England
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2012年 / 15卷
关键词：
D O I：
10.7448/IAS.15.6.18331
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：56 / 56
页数：1
相关论文
共 50 条
  • [31] Population Pharmacokinetics of Lopinavir/Ritonavir (Kaletra) in HIV-Infected Patients
    Lopez Aspiroz, Elena
    Santos Buelga, Dolores
    Cabrera Figueroa, Salvador
    Lopez Galera, Rosa Maria
    Ribera Pascuet, Esteban
    Dominguez-Gil Hurle, Alfonso
    Garcia Sanchez, Maria Jose
    THERAPEUTIC DRUG MONITORING, 2011, 33 (05) : 573 - 582
  • [32] EFFICACY AND SAFETY OF ONCE DAILY MARAVIROC PLUS LOPINAVIR/RITONAVIR IN ANTIRETROVIRAL NAIVE HIV-INFECTED PATIENTS
    Nozza, S.
    Antinori, A.
    Mazzotta, F.
    Calbi, C.
    Di Pietro, M.
    Galli, L.
    Tommasi, C.
    Fezza, R.
    Narciso, P.
    Tambussi, G.
    Lazzarin, A.
    INFECTION, 2011, 39 : S34 - S35
  • [33] Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48
    Ortiz, Roberto
    DeJesus, Edwin
    Khanlou, Homayoon
    Voronin, Evgeniy
    van Lunzen, Jan
    Andrade-Villanueva, Jaime
    Fourie, Jan
    De Meyer, Sandra
    De Pauw, Martine
    Lefebvre, Eric
    Vangeneugden, Tony
    Spinosa-Guzman, Sabrina
    AIDS, 2008, 22 (12) : 1389 - 1397
  • [34] Low-dose, once-daily atazanavir/ritonavir (200/100): An effective treatment for HIV-infected patients in Thailand
    Chetchotisakd, Ploenchan
    Anunnatsiri, Siriluck
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 49 (02) : 230 - 231
  • [35] Pharmacokinetic Study of Dual Therapy With Raltegravir 400 mg Twice Daily and Darunavir/Ritonavir 800/100 mg Once Daily in HIV-1-Infected Patients
    Martinez-Rebollar, Maria
    Munoz, Ana
    Perez, Inaki
    Hidalgo, Susana
    Brunet, Merce
    Laguno, Montserrat
    Gonzalez, Ana
    Calvo, Marta
    Lonca, Montserrat
    Blanco, Jose Luis
    Martinez, Esteban
    Maria Gatell, Jose
    Mallolas, Josep
    THERAPEUTIC DRUG MONITORING, 2013, 35 (04) : 552 - 556
  • [36] Lamivudine plus darunavir boosted with ritonavir as simplification dual regimen in HIV-infected patients
    Luis Casado, Jose
    Banon, Sara
    Moreno, Ana
    Diaz de Santiago, Alberto
    Gomez, Cristina
    Perez-Elias, Maria J.
    Moreno, Santiago
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 188 - 188
  • [37] Pharmacokinetics, Short-term Safety and Efficacy of the Approved Once-daily Darunavir/Ritonavir Dosing Regimen in HIV-infected Children
    Bastiaans, Diane E. T.
    Geelen, Sibyl P. M.
    Visser, Eline G.
    van der Flier, Michiel
    Vermont, Clementien L.
    Colbers, Angela P. H.
    Roukens, Monique
    Burger, David M.
    van Rossum, Annemarie M. C.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2018, 37 (10) : 1008 - 1010
  • [38] Efficacy and safety of once-daily maraviroc plus ritonavir-boosted darunavir in pretreated HIV-infected patients in a real-life setting
    Macias, J.
    Recio, E.
    Marquez, M.
    Garcia, C.
    Jimenez, P.
    Merino, D.
    Munoz, L.
    Pasquau, J.
    Ojeda, G.
    Bancalero, P.
    Chueca, N.
    Pineda, J. A.
    HIV MEDICINE, 2014, 15 (07) : 417 - 424
  • [39] Pharmacokinetic profile and safety of 150 mg of maraviroc dosed with 800/100 mg of darunavir/ritonavir all once daily, with and without nucleoside analogues, in HIV-infected subjects
    Mora-Peris, Borja
    Croucher, Adam
    Else, Laura J.
    Vera, Jaime H.
    Khoo, Saye
    Scullard, George
    Back, David
    Winston, Alan
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (06) : 1348 - 1353
  • [40] Once-daily darunavir/ritonavir vs. lopinavir/ritonavir in treatment-naive, HIV-1-infected patients: 96-week analysis
    Mills, Anthony M.
    Nelson, Mark
    Jayaweera, Dushyantha
    Ruxrungtham, Kiat
    Cassetti, Isabel
    Girard, Pierre-Marie
    Workman, Cassy
    Dierynck, Inge
    Sekar, Vanitha
    Abeele, Carline Vanden
    Lavreys, Ludo
    AIDS, 2009, 23 (13) : 1679 - 1688
12345